Today took place the Forum on Next-generation Bioengineering organized by the Institute for Bioengineering of Catalonia (IBEC) and Ulsan National Institute of Science & Technology (UNIST) in South Korea. The event highlighted cutting-edge research in bioengineering and reinforced the collaborative ties between the two institutions.
Today, the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) held a matchmaking workshop. The event brought together leading researchers from both centres to encourage the formation of new connections and promote scientific dialogue.
Carlos Moreno Yruela, who is currently a researcher at the Swiss Federal Institute of Technology in Lausanne, Switzerland, was selected in the ERC Starting Grants call to develop the CHEMTUBIO project at the Institute for Bioengineering of Catalonia (IBEC). The project will study the chemistry of enzymes that erase microtubule modifications. These enzymes are essential for the functioning of our cells and have shown great promise as potential therapeutic targets for treating cancer, heart disease and neurological disorders.
The Institute for Bioengineering of Catalonia (IBEC), a CERCA centre, is pleased to announce that Dr Teresa Sanchis, Head of Strategy at IBEC, has been appointed Director General of Research at the Department of Research and Universities of the Government of Catalonia. This appointment recognises her scientific career and commitment to research management.
The Institute for Bioengineering of Catalonia (IBEC) attended the opening of the exhibition, which highlights extinct fauna that remains present in the collective imagination. The exhibition includes a section dedicated to the Tasmanian tiger featuring a piece by Antoni Muntadas, on which IBEC collaborated with Benedetta Bolognesi, a principal investigator at the institute.
IBEC researcher Juanma Fernández recently has received funding from the French AFM-Telethon to carry out the project “Monitoring of fibrotic processes in 3D skeletal muscle co-cultures for Muscular Dystrophies using plasmonic biosensors”. The objective is to develop multiplexing sensor devices to achieve online, real-time sensing capability to monitor fibrosis markers and evaluate drug response in muscular dystrophy in vitro models.
The Institute for Bioengineering of Catalonia (IBEC) and the Catalan Health Institute (ICS) have signed a framework collaboration agreement to promote joint research, innovation and technology transfer activities in the field of bioengineering for health applications.
Seven more research groups at the Institute for Bioengineering of Catalonia (IBEC) have been certified by My Green Lab, reaching the highest rating, the Green Level, for sustainable laboratory practices. With these additions, IBEC core facilities and 70% of the Institute’s laboratories are now certified.
The Barcelona Science Park hosted today’s conference, “Reforming research evaluation to promote scientific quality and impact: Experiences and trends within the framework of the Coalition for Advancing Research Assessment (CoARA)”. The event was organised by the Institute for Bioengineering of Catalonia (IBEC), the CERCA Institution and the University of Carthage, and was co-funded by the CoARA coalition and the European Union.
The first collaboration day between the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute was held today at the Barcelona Biomedical Research Park (PRBB). The meeting provided an opportunity to share research projects, identify areas for collaboration and formalise a strategic alliance through the signing of a collaboration agreement between IBEC, the Hospital del Mar and the Hospital del Mar Research Institute.